comparemela.com

Astrana Health (NASDAQ:ASTH – Get Free Report) was upgraded by Baird R W to a “strong-buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. ASTH has been the topic of several other reports. Truist Financial upped their target price on Astrana Health from $41.00 to $44.00 and gave the […]

Related Keywords

United States ,Robertw Baird ,Stifel Nicolaus ,Astrana Health Inc ,News Ratings For Astrana Health Daily ,Nasdaq ,Astrana Health Stock Performance ,Jefferies Financial Group ,Astrana Health ,Get Free Report ,Care Partners ,Care Delivery ,Astrana Health Daily ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.